Papillary muscle ventricular ectopy ablation in a malignant mitral valve prolapse: Ablation in Malignant Mitral Valve Prolapse: Ablation in Malignant Mitral Valve Prolapse.
Sergio ContiFrancesco SabatinoCarlo CasertaGiuseppe SgaritoPublished in: Echocardiography (Mount Kisco, N.Y.) (2023)
Patients with mitral valve prolapse (MVP) have a heterogeneous clinical spectrum, ranging from benign to severe clinical presentations such as sudden cardiac death (SCD). Some of the markers of "arrhythmic MVP" include inverted/biphasic T-waves, QT prolongation, and polymorphic premature ventricular contractions (PVCs) originating from the left ventricular outflow tract and papillary muscles (PMs). The genesis of arrhythmias in MVP recognizes the combination of the substrate (fibrosis) and the trigger (mechanical stretch). Therefore, ablation of ventricular arrhythmias originating from PMs in a patient with MVP can be considered an adjunctive strategy to lower the arrhythmic burden and reduce the risk of ICD shocks.
Keyphrases
- mitral valve
- left ventricular
- catheter ablation
- left atrial
- heart failure
- hypertrophic cardiomyopathy
- atrial fibrillation
- cardiac resynchronization therapy
- radiofrequency ablation
- acute myocardial infarction
- aortic stenosis
- urinary incontinence
- drug induced
- skeletal muscle
- coronary artery disease
- acute coronary syndrome